Pirfenidone and Paclitaxel Diminish Triple-Negative Breast Cancer
In a groundbreaking study on triple-negative breast cancer (TNBC), researchers have unveiled a promising therapeutic strategy that could reshape how we approach this aggressive form of cancer. Combining two existing drugs, pirfenidone and paclitaxel, …